You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oncolytic Poliovirus

Showing 1 - 25 of 215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Invasive Breast Cancer Trial in Durham (PVSRIPO)

Recruiting
  • Invasive Breast Cancer
  • PVSRIPO
  • Durham, North Carolina
    Duke University Medical Center
Aug 4, 2021

GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

Completed
Has Results
  • GBM
  • +3 more
  • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
  • Durham, North Carolina
    Duke University Medical Center
Jun 28, 2022

Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)

Recruiting
  • Malignant Tumor
  • Oncolytic Virus SDJ001
  • Oncolytic Virus YD06-1
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 6, 2023

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

Active, not recruiting
Has Results
  • Metastatic Non-small Cell Lung Cancer
  • Metastatic Triple-negative Breast Cancer
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Cancer Center
Dec 28, 2022

Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 11, 2023

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Cancer, Cancer of Pancreas, Sarcoma Trial (STI-1386)

Not yet recruiting
  • Cancer
  • +4 more
  • (no location specified)
Dec 15, 2022

Hepatocellular Carcinoma Trial (Oncorine, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 30, 2023

Poliomyelitis Trial in Dhaka (SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine

Recruiting
  • Poliomyelitis
  • SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
Dec 24, 2022

Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Newport Beach, Orlando (GL-ONC1 alone, or in

Completed
  • Ovarian Cancer
  • +2 more
  • GL-ONC1 alone, or in combination with chemotherapy with or without bevacizumab
  • Newport Beach, California
  • +1 more
Jan 3, 2023

Advanced Solid Tumor Trial in Boston (VAX014)

Not yet recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 2, 2023

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)

Recruiting
  • Oncolytic Virus
  • +2 more
  • Ad-TD-nsIL12
  • Beijing, Beijing, China
    Sanbo Brain Hospital, Capital Medical University
Jan 29, 2023

Poliomyelitis Trial (nOPV2)

Not yet recruiting
  • Poliomyelitis
  • nOPV2
  • (no location specified)
Dec 22, 2022

Malignant Glioma Trial in United States (PVSRIPO)

Active, not recruiting
  • Malignant Glioma
  • PVSRIPO
  • San Francisco, California
  • +5 more
Jun 28, 2022

Metastatic Tumor, Advanced Tumor Trial in France (Pexa-Vec, Ipilimumab)

Completed
  • Metastatic Tumor
  • Advanced Tumor
  • Bordeaux, France
  • +4 more
Jul 22, 2022

Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

Recruiting
  • Platinum-refractory Ovarian Carcinoma
  • Platinum-resistant Ovarian Cancer
  • TILT-123
  • Pembrolizumab
  • Rochester, Minnesota
  • +1 more
Aug 12, 2022

Uterine Cervical Tumors Trial in Wuhan (BS-006)

Not yet recruiting
  • Uterine Cervical Neoplasms
  • BS-006
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 6, 2022